Effectiveness of Tobacco Cessation Interventions in Sweden
NCT ID: NCT04819152
Last Updated: 2022-08-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
8000 participants
OBSERVATIONAL
2020-04-09
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Though the smoking prevalence is relatively low in Sweden in an international context (8% and 10% for men and women respectively in 2016), specific vulnarable groups have a very high prevalence; e.g. about 80% in alcohol and drug abusers. Furthermore, Sweden has a unique high prevalence of snus users and in 2016 the daily use of tobacco was 25% for men and 14% for women. In addition, products such as cigarettes, snus, and e-cigettes are often mixed.
Despite the fact that about a thousand counsellors have been trained in manual-based person-centred tobacco cessation interventions in Sweden, the effectiveness of the interventions remains unknown, as a follow-up on effect of in-person interventions is not systematically collected in Sweden. Therefore, as of today it is not possible, on a national level, to compare the effectiveness of differences in these interventions, providers, or different groups of tobacco users including disadvantaged and vulnerable groups.
In this study the investigators will evaluate the effectiveness of already implemented in-person cessation interventions targeting smoking, use of snus and/or e-cigarettes, focusing on disadvantaged and vulnerable groups of tobacco users. Furthermore, important factors associated with a successful outcome after controlling for confounders will be identified (in relation to programme, patients and setting).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of the Swedish National Tobacco Quitline
NCT02085616
Substance Use Disorders and Tobacco Habits
NCT03118011
Brief Intervention Study for Quitting Smoking
NCT01589211
Smoking Cessation: Financial Incentives
NCT03849092
Tobacco Use and the Risk of COVID-19 and Adverse Outcomes
NCT05321433
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exposed
Several studies will be performed based on this cohort. I each study the exposed group will be a group of tobacco users evaluatedin the relevant study. This could be a vulnarable group tobacco users such as: users without a job, with short or no education, without permanent housing, diagnosed with mental illness, diagnosed with chronic obstructive pulmonary disease (COPD), undergoing surgery, adolescents, elderly, migrants, or pregnant women.
Tobacco cessation intervention
Already implemented in-person (including online meetings) tobacco cessation interventions in Sweden
Unexposed
In each study the unexposed group will consist of tobacco user from the study cohort without the condition examined in the relevant study.
Tobacco cessation intervention
Already implemented in-person (including online meetings) tobacco cessation interventions in Sweden
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tobacco cessation intervention
Already implemented in-person (including online meetings) tobacco cessation interventions in Sweden
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Both individual and group-based interventions can be included.
Exclusion Criteria
* Reduced ability to give informed consent, due to inadequate language skills, dementia, and other conditions.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lund University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hanne Tonnesen
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hanne Tønnesen, DSc
Role: PRINCIPAL_INVESTIGATOR
Lund University, Clinical health promotion centre
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tobaksavvänjningen, Kirurgisk mott., CLV Växjö lasarett
Vaxjo, Kronoberg County, Sweden
Capio Go
Malmo, Skåne County, Sweden
Livsstilsmedicin Österåsen
Sollefteå, Västernorrland County, Sweden
Tobakspreventiva enheten, USÖ
Örebro, , Sweden
Tybble vårdcentral
Örebro, , Sweden
Ekeby Hälsocenter
Uppsala, , Sweden
Flogsta vårdcentral
Uppsala, , Sweden
Tobakspreventiv mottagning Karlskoga
Karlskoga, Örebro County, Sweden
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
M Uneklint
Role: primary
A Karlsson
Role: primary
A Mähler
Role: primary
A Stenius
Role: backup
M Larsson
Role: primary
M Larsson
Role: primary
K Brudin
Role: primary
I Granlund
Role: primary
M Randén
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Rasmussen M, Larsson M, Gilljam H, Adami J, Warjerstam S, Post A, Bjork-Eriksson T, Helgason AR, Tonnesen H. Effectiveness of tobacco cessation interventions for different groups of tobacco users in Sweden: a study protocol for a national prospective cohort study. BMJ Open. 2022 Jan 25;12(1):e053090. doi: 10.1136/bmjopen-2021-053090.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Dnr: 2019-02221
Identifier Type: OTHER
Identifier Source: secondary_id
2017-01681
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
Rökstoppsprojektet
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.